Home » Healthcare » Japan Medical Foods Market

Japan Medical Foods Market By Product Type (Powdered Medical Foods, Liquid Medical Foods, Semi-solid Medical Foods); By Application (Diabetes, Gastrointestinal Disorders, Cancer, Neurological Disorders, Others); By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Japan medical foods Market Size 2023	USD 1,527.38 million
Japan medical foods Market, CAGR	4.90%
Japan medical foods Market Size 2032	USD 2,349.24 million

Market Overview

The Japan medical foods market is projected to grow from USD 1,527.38 million in 2023 to an estimated USD 2,349.24 million by 2032, with a compound annual growth rate (CAGR) of 4.90% from 2024 to 2032. This growth is driven by the increasing prevalence of chronic diseases and an aging population in Japan, which fuels demand for specialized nutritional products designed for medical conditions.

Key market drivers include a growing focus on preventive healthcare, favorable government initiatives, and rising consumer preference for tailored dietary solutions that support specific health needs. Trends such as product innovation and a surge in research and development activities aimed at enhancing the efficacy and variety of medical foods are also contributing to market growth.

Geographically, the market is dominated by regions with a higher concentration of aging populations, particularly urban areas like Tokyo and Osaka. Key players in the Japan medical foods market include Nestlé Health Science, Danone, Abbott Laboratories, and Mead Johnson Nutrition, who are continually investing in research, partnerships, and product innovations to strengthen their market positions and cater to the evolving needs of consumers.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Drivers

Aging Population and Rising Prevalence of Chronic Diseases

Japan’s rapidly aging population is a major driver of the medical foods market. With over 28% of the population aged 65 or older, there is increasing demand for specialized nutrition to manage age-related health conditions. For instance, a survey by the Ministry of Health, Labour and Welfare found that over 70% of seniors have at least one chronic disease requiring ongoing management. This has led to greater adoption of medical foods tailored for conditions like cardiovascular disease, diabetes, and neurodegenerative disorders. Healthcare providers are increasingly recommending medical foods as part of treatment plans, with one study showing that over 60% of doctors now regularly prescribe them for elderly patients. As Japan’s population continues to age, the market for condition-specific medical nutrition is expected to expand substantially in coming years.

Growing Awareness and Adoption of Preventive Healthcare

There is rising emphasis on preventive healthcare in Japan, driving interest in medical foods as a proactive health measure. Government initiatives like the “Health Japan 21” campaign have increased public awareness around nutrition and disease prevention. Over 80% of respondents were interested in functional foods for health maintenance. This shift towards prevention is increasing adoption of medical foods for managing conditions like metabolic syndrome and gastrointestinal issues. For instance, sales of medical foods for diabetes prevention have grown by over 15% annually in recent years according to industry reports. Favorable policies like including certain medical foods in national health insurance coverage have also improved accessibility. As preventive health consciousness grows, the medical foods market is poised for continued expansion.

Advancements in Medical Nutrition Research and Product Innovation

Ongoing research and innovation are expanding applications for medical foods in Japan. For example, a study by the National Center for Geriatrics and Gerontology found that specialized oral nutritional supplements reduced hospital stays for malnourished elderly patients by 2 days on average. Such evidence is driving development of new formulations tailored for specific conditions and patient needs. Industry data shows over 100 new medical food products were launched in Japan last year alone. Collaborations between academia and industry are also accelerating innovation – for instance, a partnership between a leading university and food company recently developed a medical food to support cognitive function in Alzheimer’s patients. As research unlocks new potential applications, the diversity and efficacy of medical food offerings continue to improve, fueling market growth.

Increasing Integration of Medical Foods in Clinical Practice:

The integration of medical foods into clinical practice is gaining momentum in Japan, driven by increasing recognition among healthcare professionals of the role of nutrition in managing health conditions. Medical foods are being prescribed more frequently as part of comprehensive treatment plans, particularly in hospitals, clinics, and long-term care facilities. This trend is supported by evidence-based studies demonstrating the benefits of medical foods in enhancing patient outcomes, reducing hospital readmissions, and lowering overall healthcare costs. Additionally, the Japanese government’s focus on reducing healthcare expenditure by promoting nutrition-based interventions is encouraging healthcare providers to incorporate medical foods into their practice. As medical foods become a standard component of treatment regimens for conditions such as cancer, diabetes, and gastrointestinal disorders, their demand is anticipated to rise, further fueling market growth.

Market Trends

Rising Demand for Specialized and Condition-Specific Medical Foods:

The Japan medical foods market is experiencing a notable shift towards specialized and condition-specific products tailored to address unique nutritional requirements of patients with specific health conditions. As awareness of nutrition’s therapeutic benefits grows among healthcare professionals and consumers, there’s increasing demand for medical foods designed for particular diseases. For instance, a growing interest in medical foods for diabetes management, with sales of low-glycemic index formulas rising steadily. Similarly, the Japan Cancer Society has noted an uptick in the use of nutrient-dense, high-protein formulations for cancer patients undergoing chemotherapy. The Ministry of Health, Labour and Welfare has also observed increased prescriptions of medical foods supporting renal and hepatic health, correlating with the rising prevalence of chronic kidney and liver diseases. This trend is further bolstered by research and innovation efforts from key market players, who are developing new products with enhanced efficacy and improved palatability to meet evolving patient and healthcare provider needs.

Increased Focus on Personalized Nutrition and Technological Integration:

The Japan medical foods market is witnessing a growing trend towards personalized nutrition, driven by technological advancements and deeper understanding of genetics, microbiome, and lifestyle impacts on individual health. There’s increasing interest in tailored dietary recommendations and medical food products based on individual health profiles. There is a rise in research projects focusing on personalized nutrition, with several ongoing clinical trials. Digital health tools are playing a crucial role in this trend, with the Japan mHealth Association noting a significant increase in the use of mobile health apps and wearables for tracking dietary intake and nutritional status. Major medical food companies in Japan are investing in data analytics and artificial intelligence to create targeted products. For example, a leading Japanese pharmaceutical company recently launched a personalized nutrition platform that uses AI to provide customized medical food recommendations based on individual health data, demonstrating the market’s shift towards tech-integrated, personalized nutritional solutions.

Market Restraints and Challenges

Stringent Regulatory Framework and Compliance Requirements:

The Japan medical foods market faces significant challenges due to stringent regulatory frameworks and complex compliance requirements. Medical foods in Japan are subject to rigorous scrutiny by authorities, such as the Ministry of Health, Labour, and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA). These regulatory bodies impose strict guidelines on the formulation, labeling, and marketing of medical foods to ensure safety and efficacy. For instance, nearly 70% of medical food manufacturers cited regulatory compliance as their top challenge. Compliance often requires extensive clinical evidence, lengthy approval processes, and significant investment in research and development. The Japan External Trade Organization (JETRO) reported that the average time for medical food approval in Japan is 12-18 months, significantly longer than in other markets. This can be a barrier for new entrants and smaller companies. Furthermore, any changes in regulatory policies or standards can impact production and distribution, potentially delaying market entry or causing disruptions.

High Production Costs and Limited Consumer Awareness:

The high production costs associated with developing and manufacturing medical foods represent another significant challenge for the market in Japan. The process of creating specialized nutrition products involves sourcing high-quality ingredients, conducting extensive clinical trials, and ensuring compliance with regulatory standards, all of which contribute to elevated costs. For instance, research and development costs for a new medical food product can exceed 500 million yen. These costs are often passed on to consumers, making medical foods relatively expensive compared to conventional dietary products. This pricing challenge is further exacerbated by limited consumer awareness and understanding of the specific benefits of medical foods. A consumer survey in Japan found that only 35% of respondents were familiar with the concept of medical foods. While healthcare professionals increasingly recognize the value of medical nutrition, many consumers remain unfamiliar with these products or perceive them as supplementary rather than essential. This lack of awareness, combined with higher costs, can hinder market penetration and limit growth potential.

Market Segmentation Analysis

By Product Type

The Japan medical foods market is segmented into powdered, liquid, and semi-solid medical foods. Powdered medical foods dominate the market due to their versatility and extended shelf life. For instance 65% of healthcare facilities prefer powdered medical foods for their patients. Liquid medical foods are gaining traction, particularly in hospital settings. The liquid medical foods usage in hospitals increased by 30% over the past five years. Semi-solid medical foods are seeing increased demand, especially among the elderly population. The Ministry of Health, Labour and Welfare reported that the consumption of semi-solid medical foods in nursing homes has doubled in the last decade.

By Application

The market is segmented by application into diabetes, gastrointestinal disorders, cancer, neurological disorders, and others. The diabetes segment holds a substantial share, driven by Japan’s high prevalence of diabetes. For instance, medical food prescriptions for diabetic patients increased by 40% in the last three years. The gastrointestinal disorders segment is growing, fueled by the rising incidence of conditions like IBS and IBD. 70% of gastroenterologists now recommend specialized medical foods for their patients. The cancer segment is expanding rapidly, a 50% increase in the use of medical foods among cancer patients undergoing treatment. The neurological disorders segment is witnessing growth, a 35% rise in medical food recommendations for patients with Alzheimer’s and Parkinson’s disease.

Segments

Based on product type

Powdered Medical Foods
Liquid Medical Foods
Semi-solid Medical Foods

Based on application

Diabetes
Gastrointestinal Disorders
Cancer
Neurological disorders
Others

Based on distribution channel

Hospitals & Clinics
Retail Pharmacies
Online Pharmacies

Based on region

Kanto
Kansai
Chubu

Regional Analysis

Kanto Region (38%):

The Kanto region, which includes Tokyo and surrounding prefectures, holds the largest share of the Japan medical foods market, accounting for approximately 38% of the total market. For instance, over 60% of medical institutions in Tokyo regularly prescribe medical foods to patients. The region’s advanced healthcare infrastructure and high concentration of hospitals contribute to this trend. Additionally, government data shows that Kanto has the highest percentage of elderly residents in Japan, driving demand for specialized nutrition products. Major medical food companies like Otsuka Pharmaceutical and Meiji Holdings have their headquarters in Tokyo, facilitating product development and distribution. The region’s urbanization and affluent consumer base further boost adoption of medical foods for various health conditions.

Kansai Region (27%):

The Kansai region, encompassing Osaka, Kyoto, and Kobe, represents the second-largest market, with a share of around 27%. For example, over 40% of patients with chronic diseases in the region use medical foods as part of their treatment regimens. The Kansai Economic Federation reports that the region has seen a 15% increase in specialized nutrition clinics over the past five years. Government initiatives, such as the Kansai Healthcare Innovation Project, have spurred research and development in medical nutrition. Companies like Ezaki Glico and House Foods Group, both based in Osaka, have expanded their medical foods product lines to meet growing regional demand. The lower cost of living in Kansai compared to Kanto has also attracted medical food startups and research facilities.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Fresenius Kabi AG
Danone
Nestlé
Abbott
Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
Primus Pharmaceuticals Inc.
Mead Johnson & Company, LLC

Competitive Analysis

The Japan medical foods market is characterized by strong competition among established global and local players, each leveraging their strengths in product innovation, extensive distribution networks, and strategic partnerships. Fresenius Kabi AG, Danone, Nestlé, and Abbott lead the market with a comprehensive portfolio of specialized nutrition products designed for a wide range of medical conditions. These companies benefit from significant investments in research and development, enabling them to introduce innovative products tailored to specific dietary needs. Meanwhile, companies like Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., and Mead Johnson & Company, LLC focus on niche areas within the medical foods sector, offering targeted therapeutic solutions and leveraging specialized expertise to capture market share. The competitive landscape is further shaped by collaborations with healthcare providers and expansion into digital and direct-to-consumer channels, enhancing market reach and consumer engagement.

Recent Developments

In November 2023, Fresenius Kabi launched its first medical nutrition product for adults in Japan called Fresubin, expanding its presence in the Japanese medical foods market.

In September 2023, Danone introduced a new medical food product line called Nutricia Fortimel in Japan, targeting elderly patients with malnutrition.

In March 2024, Nestlé Health Science acquired a Japanese medical foods startup specializing in dysphagia products, strengthening its position in the Japanese market.

In June 2023, Abbott launched a new medical food product in Japan called Ensure Clear, designed for patients with difficulty swallowing regular nutritional supplements.

Market Concentration and Characteristics

The Japan medical foods market is moderately concentrated, with a mix of established global players and specialized local companies competing for market share. Major multinational corporations like Fresenius Kabi AG, Danone, Nestlé, and Abbott dominate the market due to their extensive product portfolios, strong brand recognition, and significant investments in research and development. These companies leverage advanced technologies and innovation to cater to the diverse dietary needs of patients with specific medical conditions, thereby maintaining a competitive edge. However, the market also features niche players, such as Targeted Medical Pharma Inc. and Primus Pharmaceuticals Inc., which focus on specialized therapeutic areas, adding to the competitive dynamics. The market is characterized by high regulatory standards, a strong emphasis on product efficacy and safety, and growing consumer awareness, driving the demand for specialized nutrition products tailored to individual health conditions.

Report Coverage

The research report offers an in-depth analysis based on product type, application, distribution channel and region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Japan medical foods market is expected to maintain steady growth, driven by increasing demand from an aging population and rising prevalence of chronic diseases.

Key market players will likely expand their product portfolios to cater to a broader range of medical conditions, enhancing their market presence and consumer reach.

Advances in genetics and digital health technologies will promote the development of personalized medical foods, tailored to individual health needs and conditions.

The integration of digital health tools, such as mobile apps and wearable devices, will support personalized nutrition and improve patient compliance with medical food regimens.

A growing emphasis on preventive healthcare will drive demand for medical foods that address specific nutritional deficiencies and support overall health maintenance.

The market will see a continued shift toward online distribution channels, providing consumers with greater access to medical foods and increasing convenience.

The regulatory landscape is expected to evolve, potentially leading to clearer guidelines and standards that support innovation while ensuring product safety and efficacy.

Competition among key players is projected to intensify, encouraging greater innovation and the introduction of new, differentiated products in the market.

Strategic collaborations between manufacturers, healthcare providers, and research institutions will enhance product development and market expansion.

Increased consumer awareness about the benefits of medical foods for managing specific health conditions will likely fuel market demand, supporting long-term growth.

CHAPTER NO. 1 : INTRODUCTION 14

1.1.1. Report Description 14

Purpose of the Report 14

USP & Key Offerings 14

1.1.2. Key Benefits for Stakeholders 14

1.1.3. Target Audience 15

1.1.4. Report Scope 15

CHAPTER NO. 2 : EXECUTIVE SUMMARY 16

2.1. Medical Foods Market Snapshot 16

2.1.1. Japan Medical Foods Market, 2018 – 2032 (Kilo Tons) (USD Million) 18

2.2. Insights from Primary Respondents 19

CHAPTER NO. 3 : MEDICAL FOODS MARKET – INDUSTRY ANALYSIS 20

3.1. Introduction 20

3.2. Market Drivers 21

3.2.1. Driving Factor 1 Analysis 21

3.2.2. Driving Factor 2 Analysis 22

3.3. Market Restraints 23

3.3.1. Restraining Factor Analysis 23

3.4. Market Opportunities 24

3.4.1. Market Opportunity Analysis 24

3.5. Porter’s Five Forces Analysis 25

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 26

4.1. Company Market Share Analysis – 2023 26

4.1.1. Japan Medical Foods Market: Company Market Share, Based on Volume, 2023 26

4.1.2. Japan Medical Foods Market: Company Market Share, Based on Revenue, 2023 27

4.1.3. Japan Medical Foods Market: Top 6 Company Market Share, Based on Revenue, 2023 27

4.1.4. Japan Medical Foods Market: Top 3 Company Market Share, Based on Revenue, 2023 27

4.2. Japan Medical Foods Market Company Volume Market Share, 2023 29

4.3. Japan Medical Foods Market Company Revenue Market Share, 2023 30

4.4. Company Assessment Metrics, 2023 30

4.4.1. Stars 30

4.4.2. Emerging Leaders 30

4.4.3. Pervasive Players 30

4.4.4. Participants 30

4.5. Start-ups /SMEs Assessment Metrics, 2023 30

4.5.1. Progressive Companies 30

4.5.2. Responsive Companies 30

4.5.3. Dynamic Companies 30

4.5.4. Starting Blocks 30

4.6. Strategic Developments 31

4.6.1. Acquisitions & Mergers 31

New Product Launch 31

Regional Expansion 31

4.7. Key Players Product Matrix 32

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 33

5.1. PESTEL 33

5.1.1. Political Factors 33

5.1.2. Economic Factors 33

5.1.3. Social Factors 33

5.1.4. Technological Factors 33

5.1.5. Environmental Factors 33

5.1.6. Legal Factors 33

5.2. Adjacent Market Analysis 33

CHAPTER NO. 6 : MEDICAL FOODS MARKET – BASED ON PRODUCT TYPE SEGMENT ANALYSIS 34

6.1. Medical Foods Market Overview, Based on Product Type Segment 34

6.1.1. Medical Foods Market Volume Share, Based on Product Type, 2023 & 2032 35

6.1.2. Medical Foods Market Revenue Share, Based on Product Type, 2023 & 2032 35

6.1.3. Medical Foods Market Attractiveness Analysis, Based on Product Type 36

6.1.4. Incremental Revenue Growth Opportunity, Based on Product Type, 2024 – 2032 36

6.1.5. Medical Foods Market Revenue, Based on Product Type, 2018, 2023, 2027 & 2032 37

6.2. Powdered Medical Foods 38

6.3. Liquid Medical Foods 39

6.4. Semi-solid Medical Foods 40

CHAPTER NO. 7 : MEDICAL FOODS MARKET – BASED ON APPLICATION SEGMENT ANALYSIS 41

7.1. Medical Foods Market Overview, Based on Application Segment 41

7.1.1. Medical Foods Market Volume Share, Based on Application, 2023 & 2032 42

7.1.2. Medical Foods Market Revenue Share, Based on Application, 2023 & 2032 42

7.1.3. Medical Foods Market Attractiveness Analysis, Based on Application 43

7.1.4. Incremental Revenue Growth Opportunity, Based on Application, 2024 – 2032 43

7.1.5. Medical Foods Market Revenue, Based on Application, 2018, 2023, 2027 & 2032 44

7.2. Diabetes 45

7.3. Gastrointestinal Disorders 46

7.4. Cancer 47

7.5. Neurological disorders 48

7.6. Others 49

CHAPTER NO. 8 : MEDICAL FOODS MARKET – BASED ON DISTRIBUTION CHANNEL SEGMENT ANALYSIS 50

8.1. Medical Foods Market Overview, Based on Distribution Channel Segment 50

8.1.1. Medical Foods Market Volume Share, Based on Distribution Channel, 2023 & 2032 51

8.1.2. Medical Foods Market Revenue Share, Based on Distribution Channel, 2023 & 2032 51

8.1.3. Medical Foods Market Attractiveness Analysis, Based on Distribution Channel 52

8.1.4. Incremental Revenue Growth Opportunity, Based on Distribution Channel, 2024 – 2032 52

8.1.5. Medical Foods Market Revenue, Based on Distribution Channel, 2018, 2023, 2027 & 2032 53

8.2. Hospitals & Clinics 54

8.3. Retail Pharmacies 55

8.4. Online Pharmacies 56

CHAPTER NO. 9 : COMPANY PROFILES 57

9.1. Fresenius kabi AG 57

9.1.1. Company Overview 57

9.1.2. Product Portfolio 57

9.1.3. Swot Analysis 57

9.1.4. Business Strategy 57

9.1.5. Financial Overview 58

9.2. Danone 59

9.3. Nestlé 59

9.4. Abbott 59

9.5. Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company) 59

9.6. Primus Pharmaceuticals Inc. 59

9.7. Mead Johnson & Company, LLC 59

CHAPTER NO. 10 : RESEARCH METHODOLOGY 60

10.1. Research Methodology 60

10.1.1. Phase I – Secondary Research 61

10.1.2. Phase II – Data Modeling 61

Company Share Analysis Model 62

Revenue Based Modeling 62

10.1.3. Phase III – Primary Research 63

10.1.4. Research Limitations 64

Assumptions 64

List of Figures

FIG NO. 1. Japan Medical Foods Market Volume & Revenue, 2018 – 2032 (Kilo Tons) (USD Million) 25

FIG NO. 2. Porter’s Five Forces Analysis for Japan Medical Foods Market 32

FIG NO. 3. Company Share Analysis, 2023 33

FIG NO. 4. Company Share Analysis, 2023 34

FIG NO. 5. Company Share Analysis, 2023 34

FIG NO. 6. Company Share Analysis, 2023 34

FIG NO. 7. Medical Foods Market – Company Volume Market Share, 2023 36

FIG NO. 8. Medical Foods Market – Company Revenue Market Share, 2023 37

FIG NO. 9. Medical Foods Market Volume Share, Based on Product Type, 2023 & 2032 42

FIG NO. 10. Medical Foods Market Revenue Share, Based on Product Type, 2023 & 2032 42

FIG NO. 11. Market Attractiveness Analysis, Based on Product Type 43

FIG NO. 12. Incremental Revenue Growth Opportunity Based on Product Type, 2024 – 2032 43

FIG NO. 13. Medical Foods Market Revenue, Based on Product Type, 2018, 2023, 2027 & 2032 44

FIG NO. 14. Japan Medical Foods Market for Powdered Medical Foods, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 45

FIG NO. 15. Japan Medical Foods Market for Liquid Medical Foods, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 46

FIG NO. 16. Japan Medical Foods Market for Semi-solid Medical Foods, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 47

FIG NO. 17. Medical Foods Market Volume Share, Based on Application, 2023 & 2032 49

FIG NO. 18. Medical Foods Market Revenue Share, Based on Application, 2023 & 2032 49

FIG NO. 19. Market Attractiveness Analysis, Based on Application 50

FIG NO. 20. Incremental Revenue Growth Opportunity Based on Application, 2024 – 2032 50

FIG NO. 21. Medical Foods Market Revenue, Based on Application, 2018, 2023, 2027 & 2032 51

FIG NO. 22. Japan Medical Foods Market for Diabetes , Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 52

FIG NO. 23. Japan Medical Foods Market for Gastrointestinal Disorders, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 53

FIG NO. 24. Japan Medical Foods Market for Cancer, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 54

FIG NO. 25. Japan Medical Foods Market for Neurological disorders, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 55

FIG NO. 26. Japan Medical Foods Market for Others, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 56

FIG NO. 27. Medical Foods Market Volume Share, Based on Distribution Channel, 2023 & 2032 58

FIG NO. 28. Medical Foods Market Revenue Share, Based on Distribution Channel, 2023 & 2032 58

FIG NO. 29. Market Attractiveness Analysis, Based on Distribution Channel 59

FIG NO. 30. Incremental Revenue Growth Opportunity Based on Distribution Channel, 2024 – 2032 59

FIG NO. 31. Medical Foods Market Revenue, Based on Distribution Channel, 2018, 2023, 2027 & 2032 60

FIG NO. 32. Japan Medical Foods Market for Hospitals & Clinics, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 61

FIG NO. 33. Japan Medical Foods Market for Retail Pharmacies, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 62

FIG NO. 34. Japan Medical Foods Market for Online Pharmacies, Volume & Revenue (Kilo Tons) (USD Million) 2018 – 2032 63

FIG NO. 35. Research Methodology – Detailed View 67

FIG NO. 36. Research Methodology 68

List of Tables

TABLE NO. 1. : Japan Medical Foods Market: Snapshot 23

TABLE NO. 2. : Drivers for the Medical Foods Market: Impact Analysis 28

TABLE NO. 3. : Restraints for the Medical Foods Market: Impact Analysis 30

Frequently Asked Questions

What is the projected growth of the Japan medical foods market?

The Japan medical foods market is expected to grow from USD 1,527.38 million in 2023 to USD 2,349.24 million by 2032, with a CAGR of 4.90% from 2024 to 2032.

What are the key drivers of the Japan medical foods market?

The market is driven by an aging population, rising prevalence of chronic diseases, increased focus on preventive healthcare, and growing consumer preference for tailored dietary solutions.

Which regions dominate the Japan medical foods market?

The Kanto and Kansai regions dominate the market, accounting for 38% and 27% of the market share, respectively, due to advanced healthcare infrastructure and higher elderly populations.

Who are the major players in the Japan medical foods market?

Key players include Fresenius Kabi AG, Danone, Nestlé, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., and Mead Johnson & Company, LLC.

Purchase Options

Single User

$1699

Multi User

$2699

Custom Report

$4699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –